{
  "docId": "019de073-42e0-708e-bbdb-4616fa343de3",
  "docSlug": "252a92bcbab8bda657ee7494bf765251",
  "documentTitle": "BioAtla | Investor Presentation Deck | 37 slides",
  "authorId": "bioatla",
  "authorName": "BioAtla",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 37,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a Gantt-style visualization to show the progression of drug candidates through clinical phases.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-42e0-708e-bbdb-4616fa343de3/7",
  "deckHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3",
  "deckJsonHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3.json",
  "deckAnchorHref": "/decks/019de073-42e0-708e-bbdb-4616fa343de3#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.33,
        "x": 0.41,
        "y": 0.33
      },
      "kind": "chart",
      "text": "Horizontal bars representing clinical trial progress for BA3011, BA3021, BA3071, and BA3182",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41e66f20-0f82-4364-a034-f150a9c031d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.11,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "IIT, investigator-initiated trial; IND, investigational new drug; NSCLC, Non-small Cell Lung Cancer; RCC, Renal Cell Carcinoma; SCCHN, Squamous Cell Carcinoma of the Head and Neck; STS, Soft Tissue Sarcoma.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "489be4d0-2047-470a-a24e-4fbee2e6a5f5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.54,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "* Phase 2 investigator-initiated trial for Ovarian Cancer ** Indications based upon tumor target expression",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff179c93-e1eb-4e82-b9ae-c02108d294e9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.72,
        "w": 0.95,
        "x": 0.03,
        "y": 0.18
      },
      "kind": "table",
      "text": "Pipeline table with columns: CAB Program, Target, Indications, IND Enabling Pre-Clinical, Phase 1 Clinical, Phase 2 Clinical, Anticipated Milestones",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "95487f0d-a0ce-4207-b275-24cb430bba89",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.75,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Focused pipeline with broad applicability of differentiated CAB assets designed to deliver near-term value",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "244ead77-90d2-4db4-8970-6a4bdef0e93b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "b5512dd6-6295-44b6-95dd-fbe6cb30bf01",
      "evidence": "chart/bar-horizontal: Horizontal bars representing clinical trial progress for BA3011, BA3021, BA3071, and BA3182",
      "confidence": 0.5
    },
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "0b136716-b96f-484f-98a5-0a3877224308",
      "evidence": "table/data: Pipeline table with columns: CAB Program, Target, Indications, IND Enabling Pre-Clinical, Phase 1 Clinical, Phase 2 Clinical, Anticipated Milestones",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "385c3c32-f435-4387-9478-dbbe8518a1f8",
      "evidence": "The slide uses horizontal bars to represent the duration and status of clinical trials across a timeline.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}